How to buy Starpharma Holdings shares | A$1.46

Starpharma Holdings Limited is a biotechnology business based in Australia. Starpharma Holdings shares (SPL) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $1.46 – a decrease of 2.01% over the previous week. Starpharma Holdings has a trailing 12-month revenue of around $6.6 million.

How to buy shares in Starpharma Holdings

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Starpharma Holdings . Find the share by name or ticker symbol: SPL. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Starpharma Holdings reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $1.46, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Starpharma Holdings . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Starpharma Holdings 's share price?

Since the stock market crash in March caused by coronavirus, Starpharma Holdings 's share price has had significant positive movement.

Its last market close was $1.46, which is 16.44% up on its pre-crash value of $1.22 and 137.40% up on the lowest point reached during the March crash when the shares fell as low as $0.615.

If you had bought $1,000 worth of Starpharma Holdings shares at the start of February 2020, those shares would have been worth $579.40 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,253.22.

Starpharma Holdings share price

Use our graph to track the performance of SPL stocks over time.

Starpharma Holdings shares at a glance

• Key figures

Information last updated 2020-10-21.

Latest market close	AUDA$1.46
52-week range	AUDA$0.645 - AUDA$1.95
50-day moving average	AUDA$1.579
200-day moving average	AUDA$1.2025
Target price	AUDA$1.44
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.04

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Starpharma Holdings stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Starpharma Holdings Limited by TradingView

Starpharma Holdings price performance over time

Historical closes compared with the close of A$1.46 on 2020-10-22

1 week (2020-10-22)	0%
1 month (2020-09-29)	-9.03%
3 months (2020-07-29)	32.13%
6 months (2020-04-29)	41.75%

1 year (2019-10-29)	32.13%
2 years (2018-10-29)	2.10%
3 years (2017-10-27)	7.35%
5 years (2015-10-29)	116.30%

Starpharma Holdings financials

Revenue TTM	$6.6 million
Gross profit TTM	$5.7 million
Return on assets TTM	-21.57%
Return on equity TTM	-39.82%
Profit margin	-221.86%
Book value	0.084
Market capitalisation	$592 million

TTM: trailing 12 months

Starpharma Holdings share dividends

We're not expecting Starpharma Holdings to pay a dividend over the next 12 months.

Starpharma Holdings share price volatility

Over the last 12 months, Starpharma Holdings 's shares have ranged in value from as little as $0.645 up to $1.95. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Starpharma Holdings 's is 1.5579. This would suggest that Starpharma Holdings 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Starpharma Holdings overview

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Frequently asked questions

• What percentage of Starpharma Holdings is owned by insiders or institutions?

  Currently 10.182% of Starpharma Holdings shares are held by insiders and 44.098% by institutions.

• When does the fiscal year end for Starpharma Holdings ?

  Starpharma Holdings 's fiscal year ends in June.

• Where is Starpharma Holdings based?

  Starpharma Holdings 's address is: 4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067

• What is Starpharma Holdings 's ISIN number?

  Starpharma Holdings 's international securities identification number is: AU000000SPL0